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Abstract: The aim of the present study was to investigate the effects of Lycium barbarum 
polysaccharides (LBP) on cisplatin-induced hair cell damage in the organ of Corti explant. 
The neonatal (P2-3) rat organ of Corti explant was exposed to cisplatin (20 μM; 48 h) with 
or without LBP pretreatment (150 and 600 μg/mL; 24 h). Hair cell loss was indicated by 
FITC-labeled phalloidin staining. The level of reactive oxygen species (ROS) and 
alteration of mitochondrial membrane potential (ΔΨm) in hair cells were analyzed using 
fluorescent probes 2′,7′-dichlorofluorescein diacetate and JC-1, respectively. The results 
showed that LBP significantly attenuated hair cell loss (p < 0.01). Hair cells pretreated with 
LBP showed significant reduction in ROS production and the decline of ΔΨm compared with 
cisplatin alone group (p < 0.01), indicating the protective effect of LBP on cisplatin-induced 
hair cell loss. Taken together, these results indicate that LBP was effective in attenuating 
cisplatin-induced hair cell loss by reducing the production of ROS and maintaining 
mitochondrial ΔΨm. 
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Cisplatin, an anti-neoplastic agent, has been widely used to treat a broad spectrum of malignant 
tumors; however, the administration of cisplatin is limited by its side effects, including ototoxicity and 
nephrotoxicity [1–3]. Increased documentation demonstrated that the generation of reactive oxygen 
species (ROS), which interferes with the antioxidant defense systems of the cochlea, played an 
important role in the pathophysiology of cisplatin-induced ototoxicity [4,5]. In the inner ear, the 
increased ROS caused by cisplatin can induce apoptosis in the cochlear hair cells as well as in the 
neurons of the spiral ganglion. Some in vitro and in vivo studies reported the protective effect of 
antioxidants against cisplatin-induced hair cell death [6,7]. 
Lycium barbarum, a traditional Chinese herbal medicine, which is widely consumed by oriental 
people, has exhibited anti-cancer and immuno-enhancing activities [8–10]. Recently, L. barbarum has 
been reported to have protective effect against oxidative damage [11–13]. Polysaccharides are the 
main components isolated from L. barbarum. Cheng et al. [14] reported that L. barbarum 
polysaccharides (LBP) significantly ameliorated liver injury, prevented the progression of   
alcohol-induced fatty liver and improved the antioxidant functions in liver. Lin et al. [15] indicated 
that at high concentration, most polysaccharide fractions were effective in scavenging superoxide 
anion, 2,2-diphenyl-1-picrylhydroxyl as well as hydroxyl radicals. In animal models, some studies 
suggested that the administration of antioxidants, including cisplatin, protects against hearing loss 
caused by noise and drugs [16,17]. 
In our previous study LBP attenuated mitochondrial swelling in spiral ganglion cells in rats treated 
with cisplatin. Given its antioxidant property, it is conceivable that LBP may be effective in preventing 
cisplatin-induced hair cell damage. Therefore, this study was aimed to investigate the effects of LBP 
on cisplatin-induced hair cell damage in the organ of Corti explant. 
2. Results and Discussion 
2.1. LBP Protection Against Cisplatin-Induced Hair Cell Death 
To assess the toxicity of cisplatin on hair cells, the organ of Corti explant was exposed to the 
cisplatin (20 μM) for 48 h. The density of hair cells was analyzed. Figure 1A shows the orderly 
arrangement of inner hair cells (IHCs) and outer hair cells (OHCs) in the control group, with the 
arrangement of OHC stereocilia in a V-shaped pattern. Our previous experiment demonstrated that 
exposure to LBP (600 μg/mL) for 72 h had no damage on hair cells (Figure 1B). Cisplatin exposure for 
48 h resulted in substantial loss of OHCs and IHCs compared with the control group (p < 0.01; Figure 1C). 
LBP pretreatment (150 and 600 μg/mL) significantly attenuated hair cell loss in comparison to 
cisplatin alone group (p < 0.01; Figures 1D,E). The number of hair cells shown in Figure 1F suggests 
that LBP can protect against cisplatin-induced hair cell loss in a dose-dependent manner. Int. J. Mol. Sci. 2011, 12 8984 
 
 
Figure 1. Effects of L. barbarum polysaccharides (LBP) on the cisplatin-induced hair cell 
loss (mean ± SD). The basal turn of cochlea was used to investigate the effect of LBP on 
cisplatin induced hair cell loss. * p < 0.01 compared with the control group; 
# p < 0.01 
compared with the cisplatin alone group. Scale bar, 20 μm. 
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2.2. LBP Reduced the Generation of ROS in Hair Cells 
The generation of ROS plays a pivotal role in the pathophysiology of cisplatin-induced hearing  
loss [4,5]. Mitochondria are the important sources for ROS in cisplatin-mediated auditory cell   
damage [18,19]. Mitochondrial ROS burst is an early upstream apoptotic signal. Oxidative damage to 
mitochondria causes the impairment of mitochondrial function and subsequently leads to cell death via 
apoptosis and necrosis [20–22]. Therefore, we investigated the level of ROS in organ of Corti explant 
using DCFH-DA. Figure 2 shows the alteration of fluorescent intensity in organ of Corti explant 48 h 
after cisplatin addition. Exposure to cisplatin (20 μM) for 6 h induced a detectable increase of 
fluorescent intensity for ROS in hair cells (data not shown). Cisplatin exposure for 48 h caused more 
than a two-fold increase in fluorescent intensity for ROS production in hair cells (p < 0.01).   
A significantly decreased level of fluorescence intensity was discovered in organ of Corti explant 
pretreated with LBP compared with the cisplatin alone group (p < 0.01). The results indicate that LBP 
can reduce generation of ROS in organ of Corti treated with cisplatin. Our results further confirm that 
LBP has a protective effect against oxidative damage. 
Figure 2. Effects of LBP on the generation of reactive oxygen species (ROS) in hair cells 
(mean ± SD). * p < 0.01 compared with the control group; 
# p < 0.01 compared with the 
cisplatin alone group. 
 
2.3. Effects of LBP on Mitochondrial ΔΨm 
An enhanced ROS will cause a decrease of mitochondrial membrane potential, which alters cellular 
energy production and starts mechanisms for the execution of apoptosis [23]. In our study, we found 
that cisplatin caused mitochondrial ΔΨm decline in hair cells and that the decline of ΔΨm can be 
attenuated by LBP (p < 0.01). As shown in Figure 3, the ratio of orange-red/green fluorescent density 
in cisplatin alone group declined by 43.5% in comparison to the control group and no significant 
difference in ΔΨm was found between control group and LBP pretreated groups. The results 
demonstrate that LBP can inhibit the decline of ΔΨm in hair cells treated with cisplatin. Our results indicate 
that LBP protects against cisplatin-induced hair cell damage by maintaining the ΔΨm in hair cells. Int. J. Mol. Sci. 2011, 12 8986 
 
 
Figure 3. Effects of LBP on mitochondrial ΔΨm in hair cells (mean ± SD). * p < 0.01 
compared with the control group. 
# p < 0.01 compared with the cisplatin alone group. 
 
2.4. Discussion 
The application of cisplatin resulted in progressive and irreversible hearing loss, which is the main 
limiting factor of the cisplatin dosage in current clinical therapeutic strategies. Ototoxicity is a   
dose-limiting side effect of chemotherapeutic treatment with cisplatin. Cisplatin-induced ototoxicity is 
initiated by its uptake into the hair cells and neurons. ROS generation in cisplatin-treated hair cells was 
closely correlated with its ototoxicity. An increased ROS will cause a decrease of mitochondrial 
membrane potential, which alters cellular energy production and starts mechanisms for the execution 
of apoptosis [20,23]. Our results showed that exposure to cisplatin (20 μM) for 6 h increased the 
generation of ROS in hair cells and about a two-fold increase in ROS production 48 h after   
cisplatin exposure. 
Many antioxidants have been used to prevent cisplatin-induced hearing loss. D-methionine was 
reported to protect cochlear antioxidant enzyme levels from cisplatin-induced decrements [24]. 
Systemic administration of D-methionine was proved to have a potential oto-protective role [25]. 
Sodium thiosulfate has also been described as a protective agent against cisplatin toxicity. Wang et al. 
reported that local application of sodium thiosulfate into the cochleae of guinea pigs prevented 
cisplatin-induced hearing loss and that a minimal loss of outer hair cells in the organ of Corti was 
found, indicating the protective effect of sodium thiosulfate against cisplatin toxicity [26]. Neuwelt et al. 
reported that sodium thiosulfate was significantly protective against cisplatin-induced ototoxicity 4 h 
after cisplatin administration [27]. 
Increasing evidence indicates that LBP has protective effect against oxidative damage [11–15]. 
Previous studies have demonstrated that LBP possessed biological activities including anti-aging,   
anti-tumor, and immune-stimulatory [8,9,28]. To the best of our knowledge, there are only a few 
studies concerning the effect of LBP on the cisplatin ototoxicity. Our current findings showed that 
LBP attenuated hair cell loss induced by cisplatin. To investigate the underlying mechanism of the 
protective effect, we further analyzed the ROS generation in hair cells treated with cisplatin with or Int. J. Mol. Sci. 2011, 12 8987 
 
 
without LBP. Our findings indicated that LBP reduced cisplatin-induced intracellular ROS in hair cells 
treated with cisplatin. 
Previous studies demonstrated that epicatechin extracted from the green tea significantly inhibited 
cisplatin-induced intracellular ROS generation in a cochlear organ of Corti-derived cell line, HEI-OC1. 
Also, epicatechin treatment prevented cisplatin-induced reduction in ΔΨm by 40% [29]. To investigate 
if the LBP can maintain the stability of ΔΨm in hair cells, we monitored the alterations of ΔΨm in hair 
cells treated with cisplatin, with or without LBP. Our results revealed that LBP inhibited the decline of 
ΔΨm in hair cells treated with cisplatin, suggesting that LBP played an important role in maintaining 
the stability of ΔΨm in hair cells. 
Our findings indicated the protective effect of LBP against cisplatin ototoxicity. The limitation in 
the present study, however, was that the protective effect of LBP against cisplatin ototoxicity in 
organotypic culture may not occur in the in vivo model. So, further research needs to be done in animal 
models to assess the protective effect of LPB. 
3. Experimental Section 
3.1. LBP Extract Processing 
The dried wolfberries (700 g) were grounded to fine powder, extracted with pure water in reflux for 
3 times (800 mL, 700 mL, 700mL) and then concentrated to a volume at 350 mL under vacuum. The 
concentrated extract was precipitated using 95% ethanol. After centrifugation and several rinses with 
absolute ethanol, the resulting precipitate was extracted with 6 times volume of 95% ethanol and 
centrifuged; then the precipitate was dissolved with water and deproteinized. The prepared solution was 
dialyzed against running distilled water for 24 h. After centrifugation with absolute ethanol, the resulted 
precipitate was vacuum-dried at 40 °C to yield a brown powder Wolfberry extract-LBP (1.8 g) [11]. The 
content of LBP was determined as 82.1% by phenol-sulfuric acid method. 
3.2. Animals and Dissection 
Newborn Sprague-Dawley rats (P2-3) were used to prepare cochlear organotypic cultures. All 
experimental procedures in this study were conducted according to current institutional guidelines for 
laboratory animal care. 
The dissection procedure is similar to that described by Zhang et al. [30]. After decapitation, the 
heads were cleaned with 75% ethanol. The scalp was removed and the skull was transected along  
mid-sagittal plane. The brain was removed to expose the posterior fossa. The temporal bones were 
freed from the posterior hemi-skulls and transferred into Petri dishes containing 4 °C PBS. The 
following procedures were performed on ice. Under a stereomicroscope, the tympanic membrane and 
annulus were laterally peeled away and the surrounding cartilages were removed to expose the 
cochlear capsule. The cochlear capsule was carefully removed away. The stria vascularis and spiral 
ligament were stripped away from the base to the apex, and the organ of Corti was separated away 
from the modiolus. Our previous experiments in adult rats indicated that the cisplatin caused hearing 
loss at frequencies of 8, 16, 24 and 32 kHz. So, in the present study, the basal turn of cochlea was used 
to investigate the effect of LBP on cisplatin induced hair cells loss. Int. J. Mol. Sci. 2011, 12 8988 
 
 
3.3. Organ of Corti Culture 
A drop (50 μL) of cool, DF12 + 10% FBS was placed in the center of a 24 × 24 mm glass coverslip 
precoated with 10 μg/mL poly-L-lysine (PLL, MW 70,000–150,000, Sigma-Aldrich, St. Louis, MO, 
USA) and placed in a 35 mm diameter culture dish (Corning, Lowell, MA, USA) and the organ of 
Corti was immersed in the DF12 + 10% FBS. Close attachment of the organ of Corti to the glass 
coverslip was established by aspirating DF12 + 10% FBS. The dish containing the cochlear explant 
was placed on the ice for half an hour, and then 1.5 mL of DF12 + 10% FBS was added to the dish. 
The organ of Corti explant was maintained at 37 °C in a 5% CO2 incubator with humidity. 
3.4. Cisplatin and LBP Treatment 
The organ of Corti explants were divided into four groups (n = 7 per treatment condition): (I) the 
organ of Corti explants cultured in DF12 + 10% FBS for 72 h as the control; (II) the organ of Corti 
explants cultured in control medium with LBP (150 μg/mL) for 24 h and subsequently exposed to 
cisplatin (20 μM) for 48 h; (III) the organ of Corti explants cultured in control medium with LBP  
(600 μg/mL) for 24 h and subsequently exposed to cisplatin (20 μM) for 48 h; (IV) the organ of Corti 
explants were cultured for an initial 24 h in control medium and then exposed to cisplatin (20 μM) for 
the next 48 h. 
3.5. Assessment of Hair Cells Death 
At the end of treatment, the specimens were fixed in 4% paraformaldehyde for 4 h in 0.1 M 
phosphate buffer (pH 7.4). Specimens were rinsed in 0.1 M PBS, incubated in 0.25% Triton X-100 for 
5 min and immersed in FITC-labelled phalloidin (1:800; Sigma-Aldrich, St. Louis, MO, USA) in PBS 
for 30 min. Labeled hair cells were observed under a fluorescence microscopy(magnification 200×; 
NIKON, Tokyo, Japan). The number of hair cells was counted at each field from a single sample. Each 
group had seven samples. The average of hair cell counts from seven samples was evaluated. 
3.6. ROS Levels in Organ of Corti Explant 
ROS production in organ of Corti explant was assayed using a fluorescent dye 2′,7′-dichlorofluorescein 
diacetate (DCFH-DA) (Beyotime Biotech, Nantong, China) after treatment with cisplatin for 48 h. 
Briefly, the supernatant of the organ of Corti explant was removed, and the specimens were washed 
twice with cold 0.01M PBS (pH 7.4) and incubated with DCFH-DA (10 μmol/L) at 37 °C for 30 min. 
After DCFH-DA treatment, the chemical was removed and the specimens were washed three times 
with PBS. The fluorescence was read at 485 nm excitation and 530 nm emission under an inverted 
fluorescence microscope. Image Pro-Plus Version 6.0 software [31] was applied for measuring the 
fluorescence intensity of at least six fields per dish. Three parallel experiments were performed. 
3.7. Measurement of Mitochondrial Membrane Potential (ΔΨm) 
Mitochondrial ΔΨm in hair cells was estimated using fluorescent probe JC-1, which exists in two 
forms: monomer and J-aggregate. JC-1, which has been widely used to assess the changes of ΔΨm, is a Int. J. Mol. Sci. 2011, 12 8989 
 
 
lipophilic fluorescent cation that incorporates into the mitochondrial membrane, where it can shift 
from aggregates to monomer due to ΔΨm decrease. At low mitochondrial ΔΨm, JC-1 exists mainly in a 
monomeric form which emits green fluorescence. At high mitochondrial ΔΨm, this molecule forms 
aggregates which emit orange-red fluorescence. The dye in the healthy cells, in which mitochondrial 
ΔΨm is high, forms J-aggregates and emits orange-red fluorescence [32]. A break-down of mitochondrial 
ΔΨm is a marker of apoptosis [33,34], resulting in a decrease of orange-red fluorescence and increase of 
green fluorescence. JC-1 was excited with a 488-nm argon laser, and the shift from orange-red to green 
fluorescence indicated the decline of ΔΨm. 
After treatment with cisplatin for 48 h, the culture medium was removed, and the cultures were 
washed twice with cold 0.01M PBS (pH 7.4) and incubated with JC-1 (Beyotime Biotech, Nantong, 
China) (5.0 μg/mL) at 37 °C for 20 min. After incubation, the chemical was removed and the specimens 
were washed three times with PBS and placed in DF12. The fluorescence was read at 488 nm 
excitation and 530 nm emission for green, and at 540 excitation and 590 emission for orange-red. The 
ratios of orange-red/green JC-1 fluorescence intensity were calculated using an inverted fluorescence 
microscope. Typically, cells with a healthy population of mitochondria with a high mitochondrial ΔΨm 
have a high ratio of orange-red/green fluorescence intensity, whereas cells with declining 
mitochondrial ΔΨm have a low ratio of orange-red/green fluorescence intensity. Image Pro-Plus 6.0 
software [31] was applied to for measuring the fluorescence intensity of at least six fields per dish. 
Three parallel experiments were performed. 
3.8. Statistical Analysis 
Fluorescence intensity for ROS and mitochondrial ΔΨm was measured using Image Pro-Plus 6.0. 
All statistical analyses were performed using stata version 10.0 software [35]. Data from at least three 
independent experiments were expressed as means ± SD. Comparisons of the means of different 
groups were made using one-way analysis of variance (ANOVA) or Kruskal-Wallis test. P-value 
below 0.05 was considered to be significant. 
4. Conclusions 
In conclusion, we show for the first time that LBP has a protective effect against cisplatin induced 
hair cell damage. The antioxidant ability of LBP plays a vital role in attenuating oxidative damage in 
hair cells induced by cisplatin. In addition, we demonstrate that the mechanism of the protective effect 
of LBP against cisplatin ototoxicity is partly attributed to the role of LBP in maintaining mitochondrial 
membrane potential. 
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